Changes in clinical and metabolic parameters after exercise therapy in patents with type 2 diabetes

Archives of Medical Science

Volumn 4, Issue 4, 2008, Pages 427-437

  Gordon, Lorenzo ^a   Morrison, Errol Y ^a   McGrowder, Donovan A ^a   Young, Ronald ^a   Garwood, David ^a   Zamora, Eslaen ^b   Alexander Lindo, Ruby L ^a   Irving, Rachael ^a   Perez Sanz, Elsa C ^c  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b Department of Saturmino Lora Hospital ^*  (Cuba)

^c Department of Postgraduate Studies   (Cuba)

Author keywords

Blood pressure; Diabetes; Exercise; Glucose; Glycosylated haemoglobin; Yoga

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; BIOCHEMISTRY; BLOOD ANALYSIS; BLOOD PRESSURE REGULATION; BODY MASS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; KINESIOTHERAPY; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; YOGA;

EID: 60249101303     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-50.
2. Olefsky JM, Nolan JJ. Insulin resistance and non-insulin-dependent diabetes mellitus: Cellular and molecular mechanisms. Am J Clin Nutr 1995; 61: 1054-7.
3. Kabadi UM, Kabadi MM. Combinations sulfonylurea and insulin therapy in diabetes mellitus. Compr Ther 1995; 21: 731-6.
4. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
5. Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus. JAMA 2006; 286: 1218-27.
6. Di Loreto C, Fanelli C, Lucidi P, et al. Make your diabetes patients walk: long-term impact of different amounts of physical activity on type 2 diabetes. Diabetes Care 2005; 28: 1295-302.
7. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Dia Qing IGT and diabetes study. Diabetes Care 1997; 20: 537-44.
8. Laaksonen DE, Lindstrom J, Lakka TA, et al. Physical activity in the prevention of type 2 diabetes. Diabetes 2005; 54: 158-65.
9. American Diabetes Association (ADA). Physical Activity/Exercise and Diabetes. Diabetes Care 2004; 27 (Suppl 1): S58-62.
10. American Obesity Association (AOA). 2005. Development of the Weight Wellness profile [online]. URL http:/www.obesity.org/education/ develop_profile.shtml.
11. Goodyear LJ, Kahn BB. Exercise, glucose transport, and insulin sensitivity. Ann Rev Med 1998; 49: 235-61.
12. Su CF, Chang YY, Pai HH, Liu IM, Lo CY, Cheng JT. Meditation of beta-endorphin in exercise-induced improvement in insulin resistance in obese Zucker rats. Diabetes Metab Res Rev 2005; 21: 175-82.
13. Shultz JA, Sprague MA, Branen LJ, Lambeth S. A comparison of views of individuals with type 2 diabetes mellitus and diabetes educators about barriers to diet and exercise. J Health Commun 2001; 6: 99-115.
14. Banzer JA, Maguire TE, Kennedy CM, O'Malley CJ, Balady GJ. Results of cardiac rehabilitation in patients with diabetes mellitus. Am J Cardiol 2004; 93: 81-4.
15. Saper RB, Eisenberg DM, Davis RB, Culpepper L, Phillips RS. Prevalence and patterns of adult yoga use in the United States: results of a national survey. Altern Ther Health Med 2004; 10: 44-9.
16. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and Alternative medicine use among adults: United States, 2002. CDC Ad Data 2004; (343): 1-19.
17. Garfinkel M, Schumacher HR Jr. Yoga. Rheum Dis Clin North Am 2000; 26: 125-32.
18. Damodaran A, Malathi A, Patil N, Shah N, Suryavansihi, Marathe S. Therapeutic potential of yoga practices in modifying cardiovascular risk profile in middle aged men and women. J Assoc Physicians India 2002; 50: 633-40.
19. Malhotra V, Singh S, Singh KP, et al. Study of yoga asanas in assessment of pulmonary function in NIDDM patients. Indian J Physiol Pharmacol 2002; 46: 313-20.
20. Malhotra V, Singh S, Tandon OP, Sharma SB. The beneficial effect of yoga in diabetes. Nepal Med Coll J 2005; 7: 145-7.
21. Singh S, Malhotra V, Singh KP, Sharma SB, Madhu SV, Tandon OP. A preliminary report on the role of yoga asanas on oxidative stress in non-insulin dependent diabetes mellitus. Indian J Biochem 2001; 16: 216-20.
22. Jain SC, Uppal A, Bhatnagar SO, Bhatnagar SO, Talukdar B. A study of response pattern of non-insulin dependent diabetes to yoga therapy. Diabetes Res Clin Pract 1993; 19: 69-74.
23. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996; 276: 637-9.
24. Kishiyama S, Carlsen J, Lawrence J, Small E, Zajdel D, Oken B. Yoga as an experimental intervention for cognition in multiple sclerosis. Int J Yoga Therapy 2002; 12: 57-62.
25. Borg G. Borg's perceived exertion and pain scales. Champaign IL: Human Kinetics 1998.
26. Kalk WJ, Constable J, Osler C, Rowe P. Evaluation of a new blood glucose meter and comparison with visually interpreted strips. S Afr Med J 1985; 67: 407-9.
27. Huggert A, St G, Nixon DA. Use of glucose oxidase, peroxidase, and o-dianisidine in determination of blood and urinary glucose. Lancet 1957; 314: 368-70.
28. Schifreen RS, Hickingbothen JM, Bowers GN. Accuracy, precision and stability in measurement of hemoglobin A1c by high performance cation exchange chromatography. Clin Chem 1980; 26: 466-72.
29. Goldfarb S, William H. Evaluation Report Micral-Test II, Boehringer Mannhein. Ann Intern Med 1998; 129: 636-42.
30. Hicks JM, Iosefsohn M, Lewis SA. Evaluation of the Beckman creatinine analyzer. Clin Chem 1979; 25: 1005-8.
31. Perloff D, Grim C, Flack J, et al. Human blood pressure determination by sphygmanometry. Circulation 1993; 88: 460.
32. Sahay BK. Yoga and diabetes. J Assoc Physicians India 1986; 34: 645-8.
33. Sahay BK, Murthy KJR, Raju PS, Madhavi S. Long term follow up on effect of yoga in diabetes in Baba Shole Ed Diabetes Research in Clinical Practice. Abstracts of XIII Congress of IDF Abstract 65-004-293-655.
34. Mercuri N, Olivera EM, Souto A, Guidi ML. Yoga practice in people with diabetes. Int J Yoga Therapy 2003; 13: 69-73.
35. Bijlani RL, Vempati RP, Yadav RK, et al. A brief but comprehensive lifestyle education program based on yoga reduces risk factors for cardiovascular disease and diabetes mellitus. J Altern Complement Med 2005; 11: 267-74.
36. Sahay BK. Role of yoga in diabetes. JAPI 2007; 55: 121-6.
37. Sahay BK. Role of yogic principles in the prevention of NIDDM in Abstracts of the 5th International Diabetes Federation Congress at Kobe 1994; 95.
38. Manjunatha S, Vempati RP, Ghosh D, Bijlani RL. An investigation into the acute and long-term effects of selected yogic postures on fasting and postprandial glycaemia and insulinemia in healthy young subjects. Indian J Physiol Pharmacol 2005; 49: 319-24.
39. Panjwani U, Gupta HL, Singh SH. Effect of Sahaja yoga practice on stress management in patients of epilepsy. Indian J Physiol Pharmacol 1995; 39: 111-6.
40. Morse DR. Relaxed exercise. Int J Psychosom 1994; 41: 17-22.
41. Guagnano MT, Pace-Palitti V, Formisano S, et al. Does holiday hypoglycaemia exist? Panminerva Med 2000; 42: 23-6.
42. Telles S, Nagarathna R, Nagendra HR. Autonomic changes during "OM" meditation. Indian J Physiol Pharmacol 1995; 39: 418-20.
43. Schell EJ, Allolio B, Schonecke OW. Physiological and psychological effects of hatha yoga exercise in healthy women. Int J Psychosom 1994; 41: 46-52.
44. VinNa J, Gomez-Cabrera M-C, LLoret A, et al. Free radicals in exhaustive physical exercise: Mechanism of production, and prevention by antioxidants. IUBMB Life 2001; 50: 271-7.
45. Chevion S, Moran DS, Heled Y, et al. PNAS 2003; 100: 5119-23.
46. Kanter MM, Lesmes GR, Kaminsky LA, Ham-Saeger J, Nequin ND. Serum creatinine and lactate dehydrogenase changes following an eighty kilometre race. Eur J Appl Physiol 2001; 57: 60-3.
47. Nies AM, Hartmann A, Grunert-Fuchs M, Poch B, Speit G. DNA damage after exhaustive treadmill running in trained and untrained men. Int J Sports Med 1996; 17: 397-403.
48. Braatvedt GD, Drury PL, Cundy T. Assessing glycaemic control in diabetes: relationships between fructosamine and HbA1c. N Z Med J 1997; 110: 459-62.
49. Miedema K, Casparie T. Glycosylated haemoglobins: biochemical evaluation and clinical utility. Ann Clin Biochem 1984; 21: 2-15.
50. Munro R, Powel J, Coumar A, Nagarathna R, Dandona P. Original research: yoga therapy for NIDDM: a controlled trial. Comp Med J 1992; 6: 66-8.
51. Mahapure HH, Shete SU, Bera TK. Effect of yogic exercise on superoxide dismutase levels in diabetics. Int J Yoga 2008; 1: 3.
52. Boule N, Haddad E, Kenny GP, Wells G, Sigal R. The effect of exercise on glycemic control and body mass in type 2 diabetes mellitus: A meta-analysis of controlled clinical trials. JAMA 2001; 286: 1218-27.
53. Manson JE, Rimm EB, Stampfer MJ, et al. Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 1991; 338: 777-8.
54. Hu FB, Sigal RJ, Rich-Edwards JW, et al. Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study. JAMA 1999; 282: 1433-9.
55. Sullivan PW, Morrato EH, Ghushchyan V, Wyatt HR, Hill JO. Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular co-morbidities in the U.S., 2000-2002. Diabetes Care 2005; 28: 1599-603.
56. Holloszy JO, Hansen PA. Regulation of glucose transport into skeletal muscle. Rev Physiol Biochem Pharmacol 1996; 128: 99-193.
57. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000; 106: 473-81.
58. Arner P. Insulin resistance in type 2 diabetes: role of the adipokines. Curr Mol Med 2005; 5: 333-9.
59. Goldstein DJ. Beneficial health effects of modest weight loss. Int Obes Relat Metab Disord 1992; 16: 397-415.
60. Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L. XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004; 27: 155-61.
61. Ibrahim HA, Vora JP. Diabetic nephropathy. Baillieres Best Pract Res Clin Endocrinol Metab 1999; 13: 239-64.
62. Jager A, van Hinsbergh VW, Kostense PJ, et al. Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes 2000; 49: 485-91.
63. Caramori ML, Fioretto P, Mauer M. The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes 2000; 49: 1399-408.
64. Tuttle KR, Puhlman ME, Cooney SK, Short R. Urinary albumin and insulin as predictors of coronary artery disease: An angiographic study. Am J Kidney Dis 1999; 34: 918-25.
65. Valmadrid CT, Klein R, Moss SE, Klein BE. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 2000; 160: 1093-100.
66. Cusaro C, Zamboni G, Chiarinotti D, et al. Hour arterial pressure in insulin-dependent diabetics and non-insulin-dependent diabetics with preserved renal function. Minerva Urol Nefrol 1999; 51: 143-8.
67. Murugesan R, Govindarajalu N, Bera TK. Effect of selected yogic practices in the management of hypertension. Indian J Physiol Pharmacol 2000; 44: 207-10.
68. Ray US, Mukhopadhyaya S, Purkayastha SS, et al. Effect of yogic exercises on physical and mental health of young fellowship course trainees. Indian J Physiol Pharmacol 2001; 45: 37-53.
69. Sivasankaran S, Pollard-Quintner S, Sachdeva R, Pugeda J, Hoq SM, Zarich SW. The effect of a six-week program of yoga and meditation on brachial artery reactivity: do psychosocial interventions affect vascular tone? Clin Cardiol 2006; 29: 393-8.
70. Singh S, Malhotra V, Singh KP, Madhu SV, Tandon OP. Role of yoga in modifying certain cardiovascular functions in type 2 diabetic patients. J Assoc Physicians India 2004; 52: 203-6.
71. Sachdeva U, Chajjer B, Dharmananda S. Effects of yogic life style program in hypertensive patients; Second Annual Conference on Yoga Therapy organised by Central Research Institute for Yoga Abstract, 1994; 79-80.
72. Selvamurthy W, Sridharan K, Ray US, et al. A new physiological approach to control essential hypertension. Indian J Physiol Pharmacol 1998; 42: 205-13.
73. Schmidt T, Wijga A, Von Zur Muhlen A, Brabant G, Wagner TO. Changes in cardiovascular risk factors and hormones during a comprehensive residential three month kriya yoga training and vegetarian nutrition. Acta Phys Scand Suppl 1997; 161: 158-62.